MRK
MERCK & CO
Health Care·Pharmaceuticals·UNITED STATES
$150.33
MCap —
as of 2026-09-04
Total
B2w
Fund
D4w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.44
Sentiment 79.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$150.33
Adaptive Mean
$153.01
-2.68 vs mean
Adaptive σ
3.07
MIDOS BB
$146.88 – $159.15
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.10
ROE
7.0%
Z +0.57
Rev Gr
5.1%
Z -0.26
EPS Gr
—
Z -0.05
OPM Gr
-37.7%
Z —
FCF Yld
4.1%
Z +0.36
EPS Surp
0.5%
Z +0.04
EPS 3mo Δ
-14.3%
Z -0.08
Fwd P/E
15.75
Z —
PEGY
0.07
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
15.54
Q6M
9.83
Q12M
11.74
MA 30/100
1.118
Bullish (MA30 > MA100)
α (Jensen)
0.9390
β (12M)
0.20
σ (12M)
0.304
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
68%
Q Percentile
99%
Divergence
-30.8
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
13.2
RS Pctl
77%
RS Decile
D8
Persistence
2w
at grade B
Options / OI Analysis
as of 2026-09-04
OI Center
$132.24
-12.0% from spot
Max Pain
$140.00
PCR (OI)
0.54
neutral
Skew
-0.42
OI Composite
-1
neutral
Direction
strong_bearish